Demirer, BusraYardimci, HulyaBasmaz, Seda Erem2024-09-292024-09-2920231056-87271873-460Xhttps://doi.org/10.1016/j.jdiacomp.2022.108354https://hdl.handle.net/20.500.14619/4845Aims: The aim of this study was to evaluate the effects of dietary advanced glycation end products (dAGE) intake, Mediterranean diet adherence screener (MEDAS), and oxidative balance score (OBS) on inflammation among individuals with type 2 diabetes. Methods: The study was conducted with 96 adults (aged between 32 and 64 years) with type 2 diabetes. The average daily dAGE intakes, energy and macronutrient intakes of the participants were taken with the three-day food consumption recording method. OBS and MEDAS score was used. At the same time, routine blood lipids, HbA1c, fasting blood glucose and inflammation marker C-reactive protein (CRP) were measured. Results: Dietary AGE intake was associated with fasting blood glucose, HbA1c, CRP and blood pressures (p < 0.01). The relationship between OBS and dAGE intake was significant (8 = -0.36; 95 % Cl = -0.500, -0.220; p < 0.001). MEDAS has a negative and statistically significant effect on dAGE intake (8 = -0.56; 95 % Cl = -0.696, -0.444; p < 0.001). There was a significant and positive effect of dAGE on CRP when other variables (MEDAS, OBS) affecting dAGE were also included in the analysis (8 = 0.79; 95 % CI = 0.664, 0.917; p < 0.001). Conclusions: Our findings may have important implications for explaining the development of inflammation in type 2 diabetes patients with high dAGE intake.eninfo:eu-repo/semantics/closedAccessDietary advanced glycation end productsDiabetesInflammationMediterranean dietArticle10.1016/j.jdiacomp.2022.1083542-s2.0-85143913259136493637Q237WOS:000903976200001Q3